RA Capital Management's Therapeutics Portfolio

Secretome Therapeutics is a clinical-stage cell therapy company that develops therapies for rare cardiac diseases.

Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.

Incyclix Bio develops small molecule inhibitors of CDKs for the treatment of advanced and resistant cancers.

Prelude Therapeutics designs and develops small molecule therapies targeting key drivers of cancer cell growth and resistance.

Adcendo is a biotech company that develops antibody-drug conjugates (ADCs) to target cancers with high unmet medical needs.

Atavistik Bio is a biotechnology company that develops precision allosteric small molecules aimed at treating metabolic diseases and cancer.

SAB Biotherapeutics is a clinical-stage biopharmaceutical development company.

VitriVax is a formulation technology company that engineers solutions to maximize the accessibility and utility of human vaccines.

Ansa Biotechnologies develops a novel DNA synthesis technology based on enzymes.

Star Therapeutics mission is to develop therapies for as many diseases as possible for millions of patients.

Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for disorders of corticosteroid excess.

Vivace Therapeutics is a venture-backed start-up dedicated to discovering and developing cancer therapeutics by targeting a novel pathway.

Elektrofi is a preclinical-stage company dedicated to redefining the standard of drug delivery by transforming the patient experience.

Halda Therapeutics is a research-stage drug discovery company.

MBX Biosciences is a preclinical-stage biotech company that creates therapies to treat rare endocrine diseases.

Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases.

Interius BioTherapeutics is a biopharmaceutical company that develops in vivo cell-specific gene medicines to treat B cell lymphomas.

Asher Bio is a biotechnology company that specializes in the fields of therapeutics builds better immunotherapy for cancer.

SeLux Diagnostics is a developer of a next-generation phenotyping platform that provides personalized antimicrobial therapies to patients.

ProfoundBio is a developer of targeted therapeutics intended for patients with cancer.

Rampart Bioscience develops gene medicines to provide long-lasting treatments for a wide range of diseases.

Expansion Therapeutics is a biotechnology company focusing on developing transformative oral medicines for severe RNA-mediated diseases.

Diagonal Therapeutics is a biotechnology startup that develops targeted therapies for cancer and genetic diseases.

Triana Biomedicines is a developer of a molecular glue discovery platform to regulate disease.

NanoMosaic provides solutions for early illness detection, prognostic monitoring, and biomarker identification.

Kinaset Therapeutics is a biopharma company that focuses on advancement of novel drugs in areas of unmet medical needs.

NexCure offers clinically intense therapies in outpatient, community settings, and other cutting-edge treatments.

Candid Therapeutics is a biotechnology company that focuses on the treatment of a range of immunological conditions.

Bicara Therapeutics develops dual-action cancer therapies, combining targeted treatments with tumor modulators for enhanced impact.

Slate Medicines develops therapeutics that target Pituitary Adenylate Cyclase-Activating Polypeptide for migraine treatment and prevention.

Immunic is a biopharmaceutical company that develops a pipeline of selective oral immunology therapies.

Coherus Biosciences develops, manufactures, and commercializes biologic therapeutics for oncology and inflammatory diseases.

Xilio Therapeutics is a biotechnology company that develops tumor-activated immuno-oncology therapies.

BioAge Labs is a clinical-stage biotechnology company that develops therapeutics to treat obesity and metabolic diseases.

Jade Biosciences is developing transformative therapies to redefine the standard of care for inflammation and immunology indications.

Ambros Therapeutics is a clinical-stage biotechnology company.

Tenaya Therapeutics a clinical-stage biotechnology company that develops novel therapies to treat heart diseases.

Wave Life Sciences is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling diseases

Invivyd develops antibodies to transcend the limitations of the human immune system and fight against viral infections.

Seres Therapeutics is a microbiome therapeutics company that develops treatments for serious diseases.

Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.